Fate Therapeutics, Inc. (FATE)
NASDAQ·Healthcare·Biotechnology
$2.13
+2.90%
Mkt Cap $241.28M
Analyst Ratings
Buy
5
Hold
1
Sell
0
Price Target (24 analysts)
$5.63
Range $3.50 – $8.00
Implied Upside
+164.3%
Consensus $5.63 vs current $2.13
NASDAQ·Healthcare·Biotechnology
$2.13
+2.90%
Mkt Cap $241.28M
Buy
5
Hold
1
Sell
0
Price Target (24 analysts)
$5.63
Range $3.50 – $8.00
+164.3%
Consensus $5.63 vs current $2.13